Page 33 - CBAC Newsletter 2015

news & announCements

novemBer 2014

A paper by Ramya Vijayakumar, a graudate student of Yoram Rudy, appeared in the November issue of the
journal Circulation. Ramya used ECGI to study the arrhythmic substrate in the hearts of 25 patients with Congenital
Long QT syndrome. This is the first study to shed light on the abnormal electrophysiology of a genetic disorder in the
intact human heart. Link: http://www.ncbi.nlm.nih.gov/pubmed/25294783

Philip Bayly received the Distinguished Faculty Award. This award recognizes outstanding commitment to the
intellectual and personal development of students. Link: http://news.wustl.edu/news/Pages/27637.aspx

Injecting beads of gel into the wall of a still-beating heart has the potential to improve the health of patients with
severe heart failure, according to a new study by Douglas Mann. Mann presented the study's findings at the Amer-
ican Heart Association (AHA) annual meeting in Chicago. Link: http://www.health24.com/News/Gel-implant-might-
help-fight-heart-failure-20141125

Igor Efimov will be the Chair of the Department of Biomedical Engineering at the George Washington University in
Washington, DC, effective July 2015. Link: http://gwtoday.gwu.edu/top-heart-researcher-chair-department-biomedi-
cal-engineering

deCemBer 2014

Samuel A. Wickline received the Chancellor’s Award for Innovation and Entrepreneurship at Washington University
in St. Louis. Wickline, the James R. Hornsby Family Professor of Biomedical Sciences, was presented with the honor
at the Faculty Achievement Awards ceremony. Link: http://news.wustl.edu/news/Pages/27753.aspx

january 2015

Lihong Wang continues to build on his groundbreaking technology that allows light deep inside living tissue during
imaging and therapy. In the Jan. 5 issue of Nature Communications, Wang reveals for the first time a new technique
that focuses diffuse light inside a dynamic scattering medium containing living tissue.
Link: http://news.wustl.edu/news/Pages/27846.aspx

Pamela Woodard led a team that designed a new imaging agent that may light up dangerous plaque in arteries.
The Food and Drug Administration (FDA) has approved for evaluating in people a nanoparticle-based imaging agent
jointly developed at Washington University School of Medicine in St. Louis and the University of California, Santa
Barbara, in collaboration with Texas A&M University. The imaging agent may illuminate dangerous plaque in arteries,
and doctors hope to use it to identify patients at high risk of stroke.
Link: http://news.wustl.edu/news/Pages/nanotechnology-plaque.aspx

FeBruary 2015

Douglas Mann presented "From Basic Science to New Treatment Strategies of Advanced Heart Failure," at the 81
st
Annual Meeting of the German Cardiac Society in Mannheim, Germany.

Cont.’d ---->
CBAC Center Heartbeat | 27